d a role in the correct sorting of Bgs1 and that Bgs1 was a new cargo of AP-1 dependent trafficking required for correct cell wall synthesis. Discussion In this study, we present several lines of evidence that suggest a role for Sip1 in Golgi/endosomal trafficking as an AP-1 accessory protein. Our study identified b-glucan synthase as a new cargo of AP-1-dependent trafficking required for correct cell wall synthesis. The sip1-i4 mutants displayed phenotypes resembling those associated with Apm1 deletion, including defects in Golgi/ endosomal trafficking and secretion, temperature- and immunosuppressant-sensitive growth, and defects in cell integrity. In addition, the sip1-i4 mutation affected AP-1 complex localization at Golgi/endosomes, which suggested a purchase KPT-9274 conserved role for Sip1 in AP-1 localization. Together with the physical interaction between Sip1 and the AP-1 complex and the co-localization of these proteins in vivo, these results strongly suggest that Sip1 is an AP-1 accessory protein. Apm1 overexpression suppressed the sip1-i4 mutant phenotypes with regard to membrane trafficking, including abnormal Syb1 localization and defects in vacuole fusion and secretion. Although most of the AP-1 complex was mislocalized in the sip1-i4 mutant cells, overproduction of Apm1 may have increased the amount of the residual AP-1 complex that was localized in the proper organelle, thereby restoring its function. Thus, sip1-i4 mutant phenotypes can be partly attributed 14 AP-1 Accessory Protein in S. pombe to the loss of proper AP-1 complex function due to its mislocalization. Importantly, our study demonstrated that Sip1 was not essential for endocytosis and that it was an endosomal and not an endocytic protein. A recent study by Jourdain et al. reported that Sip1 was an endocytic vesicle protein that was important for endocytosis. Jourdain et al. assigned Sip1 to endocytic vesicle, since it did not co-localize with a Golgi marker, it was only partially localized with a trans-Golgi marker, and it co-localized with internalized FM4-64. This pattern could also describe endosomal localization. Our study demonstrated Sip1 endosomal localization based on its co-localization with Apm1 and FM4-64 at an early stage of endocytosis. The sip1-i4 mutation resulted in a termination codon at amino acid position 1434 located within the highly conserved region, which contains an approximately 200-amino acid segment conserved throughout evolution in this protein family. This mutation resulted in a truncated protein product that lacked 485 amino acids at the C-terminus of the Sip1 protein. Studies of budding yeast Laa1 showed that the HCR was dispensable for its interaction with AP-1, but was necessary for the localization of Laa1 to the punctuate structures. Therefore, the Sip1-i4 mutant protein may behave like 
Laa1DHCRp and, thus, supports the importance of HCR in AP-1 localization. This also narrows down the region within the HCR that is important for AP-1 localization. In addition, the effect of the sip1-i4 mutation was more pronounced than the budding yeast Laa1DHCRp, as the AP-1 complex appeared to be almost completely mislocalized in cells with the sip1-i4 mutation, even during the early PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22210737 logarithmic phase. We also showed that both the sip1-i4 and sip1-62 mutants displayed similar phenotypes, including hypersensitivity to temperature, the immunosuppressive drug FK506, valproic acid, and micafungin. In addition, both mutant cells exhibited cytokinesis defect a
